Guardant Health has developed a new FDA-approved blood test designed to detect colorectal cancer, and it's now available to patients in North Texas.

An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. While scientists believe that gut microbiota play an ...